Page 59 - Aet News Today

Takeda Pharmaceutical enzyme replacement drug Adzynma is the first FDA-approved therapy for a rare blood disorder affecting fewer than 1,000 Americans. Our regulatory recap also includes the much-anticipated approval of an Eli Lilly weight loss drug and a crackdown on what the FTC says are improperly listed pharma product patents.

In this episode, we're joined by Melissa Tran, a marriage and family therapist and the military sexual trauma coordinator at the Orlando VA. She's here to discuss the unique challenges female veterans face and the programs she's helping build for this population.

It is important to understand that the performance of over-the-counter hearing aids can vary widely from prescription hearing aids due to a number of factors.

To digitize healthcare and lean on the emerging technologies is to find the opportunity within the relationship between machine and human to augment humans’ ability to be human – to empathize and provide the compassionate touch to care.

In total, there are 3,959 Medicare Advantage plans being offered for individual enrollment in 2024, a 1% decrease from 2023, according to a new report from KFF.

About 85,000 Kaiser Permamente workers voted to ratify a new contract, putting to end what was the largest strike in the history of the healthcare industry. The new contract includes terms for higher wages, more employee education, increased hiring and retention efforts, and greater involvement of frontline workers in the health system’s staffing decisions.

Real-time insights enable laboratories to be more proactive, strategic, and responsive in managing their staffing needs and mitigating the impact of market forces affecting labor shortages.

As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic profile.

One of the major lessons learned during the pandemic is that hospitals and medical facilities are not always the safest places to recover, especially for seniors and those living with chronic conditions. Compounding this issue is that 85% of seniors in the U.S. live with one or more chronic conditions. With the United States being home to 55.8 million seniors, this is a very real, local issue. The home is often the most comfortable, convenient and safe place to recover from an illness, injury, ...

Cargo Therapeutics will use most of the IPO proceeds for clinical testing of a cell therapy engineered to overcome a common way cancers develop resistance. This program is based on research from the National Cancer Institute.